Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (331-340 of 424) with videos related to

Pageof 43
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1997
Pancreaticogastrostomy after pancreatoduodenectomy. A retrospective study of 28 patientsA J Pikarsky, M Muggia-Sullam, A Eid, et al.
Gynecologic Oncology|August 1, 1997
Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin)F M Muggia, S Jeffers, L Muderspach, et al.
Cancer Treatment Reports|April 1, 1984
Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancerM D Green, J S Speyer, J C Bottino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Cellular but not plasma pharmacokinetics of lometrexol correlate with the occurrence of cumulative hematological toxicityT W Synold, E M Newman, M Carroll, et al.
Gynecologic Oncology|May 28, 2019
Decreasing secondary primary uterine cancer after breast cancer: A population-based analysisKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
Gynecologic Oncology|February 10, 2004
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyFranco M Muggia, John A Blessing, Michael Method, et al.
Gynecologic Oncology|August 1, 1993
Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimensF M Muggia, S Groshen, C Russell, et al.
Investigational New Drugs|August 1, 1990
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancerM D Green, J L Speyer, J C Wernz, et al.
Gynecologic Oncology|December 14, 2004
Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group StudyFranco M Muggia, John A Blessing, Steven Waggoner, et al.
Archives of Gynecology and Obstetrics|March 3, 2019
Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective studyErin A Blake, Chrystal A Bradley, Sayedamin Mostofizadeh, et al.
Pageof 43

Showing results (331-340 of 424) with videos related to

Sort By:
Pageof 43
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1997
Pancreaticogastrostomy after pancreatoduodenectomy. A retrospective study of 28 patientsA J Pikarsky, M Muggia-Sullam, A Eid, et al.
Gynecologic Oncology|August 1, 1997
Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin)F M Muggia, S Jeffers, L Muderspach, et al.
Cancer Treatment Reports|April 1, 1984
Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancerM D Green, J S Speyer, J C Bottino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Cellular but not plasma pharmacokinetics of lometrexol correlate with the occurrence of cumulative hematological toxicityT W Synold, E M Newman, M Carroll, et al.
Gynecologic Oncology|May 28, 2019
Decreasing secondary primary uterine cancer after breast cancer: A population-based analysisKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
Gynecologic Oncology|February 10, 2004
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyFranco M Muggia, John A Blessing, Michael Method, et al.
Gynecologic Oncology|August 1, 1993
Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimensF M Muggia, S Groshen, C Russell, et al.
Investigational New Drugs|August 1, 1990
Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancerM D Green, J L Speyer, J C Wernz, et al.
Gynecologic Oncology|December 14, 2004
Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group StudyFranco M Muggia, John A Blessing, Steven Waggoner, et al.
Archives of Gynecology and Obstetrics|March 3, 2019
Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective studyErin A Blake, Chrystal A Bradley, Sayedamin Mostofizadeh, et al.
Pageof 43